BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-11-18 anan-prove 来自山东省

偏重的研究方向：小鼠模型;肿瘤免疫检查点
经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？

22 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-11-21 ms2000001788822130 来自上海

BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文
审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确
想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-10-25 ms1000001788822128 来自北京

审稿速度:1.0
经验分享：已改头了
9.22投的research article，不是letter
10月10号收到编辑意见
要求让提供wb的原始的未裁剪的全膜等内容
奈何我没有，只好告辞了😂

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-10-26 ms1000001329023051

10.16投稿，现在还是submted to jounral

29 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-10-13 ms1000001788822100 来自上海

审稿速度:6.0
经验分享：前后总共耗时2个多月
6月初提交差不多一周后送审
7.14 一审结束
8.29二审
9.17二审结束，仍有两三条小意见
9.20 返修后继续送审
9.25接受

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-10-23 ms1000001788822123 来自北京

审稿速度:2.0 | 投稿命中率:75.0
经验分享：记录一下，希望能帮到大家
3月25号投稿
3月28号进入审稿阶段（under review）
并在4月14号收到审稿意见
状态变为revise并给了一个月时间修改。
5月5号修稿后，状态一直是with editor
5月7号变成Decision in process，第二天直接接收

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-07-22 biocell160 来自贵州省

偏重的研究方向：肿瘤
经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！

186 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-05-15 ms5000001887550518 来自天津

偏重的研究方向：细胞生物学
经验分享：最近怎么这么慢，快20天了依然submitted

190 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-10-13 ms1000001788820099 来自上海

审稿速度:3.0 | 投稿命中率:50.0
经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右
审稿很严格，编辑也比较负责。
有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2237535, encodeId=db55223e535c0, content=偏重的研究方向：小鼠模型;肿瘤免疫检查点 经验分享：想问问大家，送审多少号了？五个figure，做了三个小鼠模型，基本都是小鼠实验。创新性一般般，这种送审几率大不大呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffff9271833, createdName=anan-prove, createdTime=Mon Nov 18 08:30:50 CST 2024, time=2024-11-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2238327, encodeId=0da4223832ea9, content=BBRC接受的投稿类型包括原创性研究、简短的交流和综述论文 审稿人对投稿作品提出了四点要求：一是符合期刊的目标受众，以吸引预期读者；二是手稿应具有原创性，并提供对具有挑战性的问题的见解；三是研究设计合理，实验和数据收集解释达到较高水平；四是手稿清晰、简洁且格式正确 想要投稿的朋友可以仔细阅读编辑决定和审稿人评语，及时回复每一条评语并注明改动, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822130, createdTime=Thu Nov 21 23:17:12 CST 2024, time=2024-11-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2233195, encodeId=a63c2233195ff, content=审稿速度:1.0 经验分享：已改头了 9.22投的research article，不是letter 10月10号收到编辑意见 要求让提供wb的原始的未裁剪的全膜等内容 奈何我没有，只好告辞了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822128, createdTime=Fri Oct 25 22:49:41 CST 2024, time=2024-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2233285, encodeId=fd7b2233285ba, content=10.16投稿，现在还是submted to jounral, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6dfd8575849, createdName=ms1000001329023051, createdTime=Sat Oct 26 19:34:23 CST 2024, time=2024-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2230670, encodeId=ac4a22306e09d, content=审稿速度:6.0 经验分享：前后总共耗时2个多月 6月初提交差不多一周后送审 7.14 一审结束 8.29二审 9.17二审结束，仍有两三条小意见 9.20 返修后继续送审 9.25接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822100, createdTime=Sun Oct 13 21:45:29 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2232764, encodeId=37752232e6470, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：记录一下，希望能帮到大家 3月25号投稿 3月28号进入审稿阶段（under review） 并在4月14号收到审稿意见 状态变为revise并给了一个月时间修改。 5月5号修稿后，状态一直是with editor 5月7号变成Decision in process，第二天直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Wed Oct 23 22:48:55 CST 2024, time=2024-10-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2216361, encodeId=5c692216361e9, content=偏重的研究方向：肿瘤 经验分享：这个杂志现在是真的慢，投稿10天了是一点反馈都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/94RcfbZgzvtj5txdt4ia4g80zFHGhkVkUnKoQc0E9WF4hZ8XdN5UlcGiabmqTRiarpOm2Es15NopPfKeVicJIsBtEA/132, createdBy=ce481603107, createdName=biocell160, createdTime=Mon Jul 22 23:06:38 CST 2024, time=2024-07-22, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2204795, encodeId=4da62204e95d1, content=偏重的研究方向：细胞生物学 经验分享：最近怎么这么慢，快20天了依然submitted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8abe9237349, createdName=ms5000001887550518, createdTime=Wed May 15 11:41:42 CST 2024, time=2024-05-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2230664, encodeId=918b2230664e3, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：BIOPHYSICAL JOURNAL的审稿速度还是较快的，8周左右 审稿很严格，编辑也比较负责。 有条件的可以找找人活机构指点指点，效率会比较快一些，流程也顺畅一些。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788820099, createdTime=Sun Oct 13 21:39:36 CST 2024, time=2024-10-13, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2230309, encodeId=e5352230309fd, content=很好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86de9491756, createdName=ms4000001946377302, createdTime=Fri Oct 11 11:08:24 CST 2024, time=2024-10-11, status=1, ipAttribution=陕西省)]

2024-10-11 ms4000001946377302 来自陕西省

很好

33 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务